Position in ANIK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,947,900
+$3,282,121 QoQ
Shares Held
272,269
+293.0% QoQ
Ownership
2.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $1,491,893,072 across 43 Drug Manufacturers - Specialty & Generic names. ANIK ranks #21 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
4,938,967 | $650,659,508 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
826,226 | $489,935,489 | |
| 3 | VTRS |
Viatris Inc
|
6,341,318 | $85,671,200 | |
| 4 | ZTS |
Zoetis Inc.
|
607,950 | $71,865,765 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
7,535,080 | $26,448,126 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
378,697 | $18,234,258 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
894,423 | $16,564,712 | |
| 8 | ALKS |
Alkermes plc.
|
383,977 | $13,577,424 |
All Filings in ANIK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,947,900 | 272,269 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $665,779 | 69,280 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $464,950 | 49,463 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $537,610 | 50,814 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $181,214 | 12,057 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $758,090 | 30,692 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,719,756 | 107,373 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,522,245 | 99,301 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,133,461 | 94,151 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,370,311 | 73,554 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $833,308 | 32,075 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $913,985 | 31,824 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $942,493 | 31,841 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $580,482 | 24,390 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $328,215 | 14,705 | Shares | Defined | 2022-08-15 | |
| 2020-09-30 | $1,903,840 | 53,796 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,444,292 | 117,792 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $3,511,032 | 121,447 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||